bevacizumab
roche
['ovarian', 'bevacizumab', 'thanks']
excited to share our work at #asco2023. thanks to my mentors dr. meyer and dr. sun, and collaborators dr. zhao, dr. primm and mr. haas why is there differential use of maintenance therapy (parpi and/or bevacizumab) in ovarian cancer among an insured cohort? 
Gyn Onc Fellow @ MDACC / @YaleObGynRes, @BrownMedicine, @HarvardChanSPH alum / Global women's health / #HealthEquity #GynCancer / Psalms 46:5 / She/her 🇬🇭